Clinical trials
Phase 2/3 Leukemia, Lymphocytic, Chronic, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| TG Therapeutics, Inc. | 2 |
| Gilead Sciences | 1 |
| M.D. Anderson Cancer Center | 1 |
| Rochester General Hospital | 1 |
| Roswell Park Cancer Institute | 1 |
| WiSP Wissenschaftlicher Service Pharma GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Burkitt Lymphoma | 2 |
| Lymphoma | 2 |
| Lymphoma, Large-Cell, Immunoblastic | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.